Abstract:Objective: To investigate the effects of sinensetin (SIN) on cartilage injury in rheumatoid arthritis (RA) rats via regulating cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) /stimulator of interferon gene (STING) signaling pathway. Methods: A RA rat model was constructed, and successfully modeled rats were randomly separated into a model group (RA group), low and high dose SIN treatment groups (SIN-L, SIN-H groups), and high dose SIN treatment+cGAS/STING signaling pathway activator DMXAA group (SIN-H+DMXAA group), with 12 rats in each group. Additionally, 12 healthy normal rats were selected as the Control group. After 14 days of treatment, the arthritis index (AI) score was performed. Enzyme-linked immunosorbent assay (ELISA) was applied to detect serum levels of inflammatory factors. Hematoxylin and eosin (H&E) staining was applied to detect the pathological morphology of joint tissues. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining was applied to detect chondrocyte apoptosis. Immunohistochemistry was applied to detect the expression of cartilage injury related proteins. Western blot was applied to detect the expression of cGAS/STING signaling pathway and apoptosis related proteins in joint tissues. Results: Compared with the Control group, the RA group showed damage to cartilage and bones, uneven surface of articular cartilage, sparse and disordered arrangement of chondrocytes, thickening of synovium, with obvious proliferation of fibrous tissue, and significantly elevated AI score, interleukin 6 (IL-6), IL-17 levels, apoptosis rate, Bax, C-caspase3, matrix metalloproteinase-1 (MMP-1), MMP-3, cGAS, and p-STING/STING expressions (P<0.05). Compared with RA group, the SIN-L and SIN-H groups presented reduced cartilage surface erosion, with more orderly arrangement of chondrocytes and reduced synovial hyperplasia and joint degeneration, and significantly reduced AI score, IL-6, IL-17 levels, apoptosis rate, Bax, C-caspase3, MMP-1, MMP-3, cGAS, and p-STING/STING expression, in a dose-dependent manner (P<0.05). Compared with the SIN-H group, the SIN-H+DMXAA group had more severe pathological damage to cartilage tissue and synovium, and significantly increased AI score, IL-6, IL-17 levels, apoptosis rate, Bax, C-caspase3, MMP-1, MMP-3, cGAS, and p-STING/STING expression (P<0.05). Conclusion: SIN can alleviate cartilage damage in RA rats via the inhibition of the cGAS-STING signaling pathway.
[1] Cush JJ.Rheumatoid arthritis:early diagnosis and treatment[J].Rheum Dis Clin North Am,2022,48(2):537-547. [2] Brown P,Pratt AG,Hyrich KL.Therapeutic advances in rheumatoid arthritis[J].BMJ,2024,384(1):70856-70874. [3] Yuan Z,Li J,Xiao F,et al.Sinensetin protects against periodontitis through binding to Bach1 enhancing its ubiquitination degradation and improving oxidative stress[J].Int Oral Sci,2024,16(1):38-47. [4] Xu A,Yang R,Zhang M,et al.Macrophage targeted triptolide micelles capable of cGAS-STING pathway inhibition for rheumatoid arthritis treatment[J].Drug Target,2022,30(9):961-972. [5] Fujii Y,Inoue H,Arai Y,et al.Treadmill running in established phase arthritis inhibits joint destruction in rat rheumatoid arthritis models[J].Int Mol Sci,2019,20(20):5100-5112. [6] Liu Z,Liu R,Wang R,et al.Sinensetin attenuates IL-1β-induced cartilage damage and ameliorates osteoarthritis by regulating SERPINA3[J].Food Funct,2022,13(19):9973-9987. [7] Yu Y,Xue X,Tang W,et al.Cytosolic DNA-mediated STING-dependent inflammation contributes to the progression of psoriasis[J].Invest Dermatol,2022,142(3):898-906. [8] Diaz-Gonzalez F,Hernandez-Hernandez MV.Rheumatoid arthritis[J].Med Clin (Barc),2023,161(12):533-542. [9] Han Jie L,Jantan I,Yusoff SD,et al.Sinensetin:an insight on its pharmacological activities,mechanisms of action and toxicity[J].Front Pharmacol,2021,11(1):553404-553419. [10] Li J,Jie X,Liang X,et al.Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings[J].BMC Complement Med Ther,2020,20(1):135-143. [11] Shen Y,Teng L,Qu Y,et al.Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating NF-κB and MAPK signaling pathways[J].Ethnopharmacol,2022,284(1):114791-114801. [12] Song C,Xu S,Chang L,et al.Preparation of EGCG decorated,injectable extracellular vesicles for cartilage repair in rat arthritis[J].Regen Biomater,2021,8(6):67-75. [13] Tang M,Zeng Y,Peng W,et al.Pharmacological aspects of natural quercetin in rheumatoid arthritis[J].Drug Des Devel Ther,2022,16(1):2043-2053. [14] Yang X,Zhao L,Pang Y.cGAS-STING pathway in pathogenesis and treatment of osteoarthritis and rheumatoid arthritis[J].Front Immunol,2024,15(1):1384372-1384385. [15] 苏蓉慧,程丽云,字晓宇,等.cGAS-STING信号通路:类风湿关节炎的潜在治疗靶点[J].中华微生物学和免疫学杂志,2024,44(5):460-467.